Guardant Health, Inc. - Common Stock (GH)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock
Shares outstanding
123,850,680
Total 13F shares
89,154,760
Share change
+4,236,839
Total reported value
$13,609,100,786
Put/Call ratio
83%
Price per share
$152.65
Number of holders
402
Value change
+$675,853,171
Number of buys
187
Number of sells
194

Institutional Holders of Guardant Health, Inc. - Common Stock (GH) as of Q1 2021

As of 31 Mar 2021, Guardant Health, Inc. - Common Stock (GH) was held by 402 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 89,154,760 shares. The largest 10 holders included VANGUARD GROUP INC, FMR LLC, SB INVESTMENT ADVISERS (UK) LTD, BlackRock Inc., MORGAN STANLEY, Clearbridge Investments, LLC, VIKING GLOBAL INVESTORS LP, JENNISON ASSOCIATES LLC, FRED ALGER MANAGEMENT, LLC, and Nuveen Asset Management, LLC. This page lists 404 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.